Encompass Health Hospital in Florida Closes Indefinitely After Flood Damage; 2026 Guidance Reaffirmed

Encompass Health's Sea Pines hospital in Florida closed indefinitely due to flood damage. The company reaffirmed its 2026 guidance, expecting $6.45–$6.50B revenue and $1.395–$1.415B Adjusted EBITDA. Sea Pines contributed $44M in revenue and $14M in EBITDA in 2026's first nine months.

Original reporting
Published Nov 6, 2026, 12:43 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 6, 2026, 12:52 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Encompass Health Hospital in Florida Closes Indefinitely After Flood Damage; 2026 Guidance Reaffirmed — source image
Decision brief

The 30-second read

$EHCBearishMed
01

Why it matters

The closure removes a $44 M revenue stream and may increase costs, likely pressuring the stock despite unchanged guidance.

02

Market read

First disclosure of a material operational disruption for EHC; investors will reassess revenue outlook and cost exposure.

03

What to watch

Potential insurance recoveries or rapid refurbishment could mitigate revenue loss.

Relevance 7/10Novelty 7/10Timing: today

Background

Encompass Health (EHC) filed an 8‑K reporting flood damage to its Sea Pines joint‑venture hospital in Melbourne, Florida, and reaffirmed its 2026 guidance.

Company-level read

Ticker impact

$EHCBearishHigh confidence
Context

Encompass Health disclosed that its Sea Pines joint‑venture hospital in Florida was flooded and will remain closed indefinitely, while reaffirming its 2026 revenue and earnings guidance.

Expected impact

likely downward pressure as investors price in lost hospital revenue and potential refurbishment costs

Evidence & confidence

The 8‑K filing is the first public disclosure of the flood damage; the guidance remains unchanged but the loss of a $44 M revenue contributor creates uncertainty.

Market effects

Highlights operational risk for healthcare operators with joint‑venture assets in flood‑prone regions.

May affect sentiment toward other Florida‑based health providers.

Limited to U.S. healthcare sector investors.

Counterpoint

Guidance reaffirmation could signal management confidence, limiting downside.

Key entities

  • Encompass Health Corp.

    U.S. healthcare provider listed on NYSE under ticker EHC.

  • Sea Pines Hospital

    90‑bed hospital in Melbourne, Florida affected by flooding.

Related articles

$EHCMed

Raymond James raises Encompass Health stock price target on strong results

Raymond James raised its price target for Encompass Health (EHC) to $155 from $150, citing strong Q3 results and raised guidance. The company beat EBITDA expectations for the 16th straight quarter, driven by acuity and cost control. EHC shares are near their 52-week high, up 32% in six months. Analysts like UBS, KeyBanc, and Truist also raised their price targets, noting strong EBITDA performance and positive 2027 outlook.

$EHCMedAI 8/10

KeyBanc raises Encompass Health stock price target on strong earnings

KeyBanc raised its price target for Encompass Health (NYSE:EHC) to $150 from $147, citing strong Q3 results. Core EBITDA beat estimates by 10% with 23% YoY growth, driven by acuity improvements and expense management. The company reported $1.52B EBITDA over the last 12 months. Same-store volumes grew 3.0%, with expectations of further improvement. Management is optimistic about 2027 and RCD expansion. The stock has returned 32% over six months, trading near its 52-week high of $133.75.

$EHCHigh

Truist raises Encompass Health stock price target on strong results

Truist Securities raised its price target on Encompass Health (NYSE:EHC) to $156 from $150, citing strong Q3 results. The company reported adjusted EBITDA of $1.52B and a 32% stock return over six months. Encompass Health raised its guidance despite headwinds and is expanding capacity. The stock trades near its 52-week high of $133.75, with a financial health score of 3.35 out of 5.

$EHCHighAI 9/10

Encompass Health Q3 Earnings Call Highlights

Encompass Health reported Q3 adjusted EBITDA of $346.6M, lowering its 2026 net provider-tax contribution forecast to $3M. Bad debt expense was 2.7% of revenue due to billing disruptions, expected to improve by year-end. Labor costs increased 3.8%, while premium labor costs fell $3.9M. The company opened new hospitals and added beds, with plans for further expansion. It raised 2026 guidance, expecting revenue of $6.45B-$6.5B and adjusted EBITDA of $1.395B-$1.415B.